To investigate whether lysosomal markers were altered in NHD brains, we quantified CD68 intensity in TMEM119+Iba-1+ microglia from control and NHD+ tissues and in tissues from one MS patient (Fig. 6g). The gene discussed is CD68; the disease is myeloid sarcoma.